" [HTML] Inhibition of MAD2L1 Mediates Pulmonary Fibrosis through Impairment of Mitochondrial Function and Induction of Cell Senescence L Wang, R Wan, X Chen, X Guo, Z Li, W Zhao, P Yan… - Canadian Respiratory …, 2022 … In this study, we a…

" Elucidation of the Anti-Fibrotic Activity of a Repurposed Drug for Idiopathic Pulmonary Fibrosis J Reardon - 2022 … , has been identified as a potential novel therapy for IPF. Spironolactone is an off-patent drug for … Thus, we aimed to …